This company listing is no longer active
Salud financiera de hoja de balance de ChemoCentryx
Salud financiera controles de criterios 4/6
Información clave
10.5%
Ratio deuda-patrimonio
US$24.92m
Deuda
Ratio de cobertura de intereses | n/a |
Efectivo | US$328.62m |
Patrimonio | US$236.53m |
Total pasivo | US$182.86m |
Activos totales | US$419.39m |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
Análisis de la situación financiera
Pasivos a corto plazo: 2CX's short term assets ($345.2M) exceed its short term liabilities ($76.1M).
Pasivo a largo plazo: 2CX's short term assets ($345.2M) exceed its long term liabilities ($106.8M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: 2CX has more cash than its total debt.
Reducción de la deuda: Insufficient data to determine if 2CX's debt to equity ratio has reduced over the past 5 years.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: 2CX has sufficient cash runway for more than 3 years based on its current free cash flow.
Pronóstico de cash runway: Insufficient data to determine if 2CX has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.